Haroon Khan is a preclinical researcher, having extensive expertise in the field of neuroscience, molecular biology and targeted drug delivery techniques. His main research interest lies in undertaking and improving preclinical research related to protection and repair of neurons after neuronal injuries. Khan has invaluable experience and has successfully completed research projects in several research directions, including: • Investigating native and engineered extracellular vesicles (EVs)/exosomes for the treatment of neurological diseases • Application of EVs as targeted drug delivery vehicle to the brain. • Stem cell engineering for therapeutic applications. • Application of CRISPR-Cas system for genetic engineering and detection of nucleic acid.